Last updated on July 2018

A Study of LY3200882 in Participants With Solid Tumors


Brief description of study

The main purpose of this study is to evaluate the safety of the study drug known as LY3200882 in participants with solid tumors.

Clinical Study Identifier: NCT02937272

Contact Investigators or Research Sites near you

Start Over

Eli Lilly and Company

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Barcelona, Spain
  Connect »